Back to search

Boston University

The uncertain world of relapsed neuroblastoma: the quest for treatment options in a complex, fatal childhood disease

Abstract

dc:description.abstract

Neuroblastoma is a highly heterogenous pediatric malignancy that newly affects 500 children in the United States every year. Neuroblastoma tumors vary greatly in terms of their genetic characteristics, chromosomal aberrations, stage of the disease, ploidy, and risk status. While certain neuroblastoma diagnoses (i.e. low-risk tumors) are usually managed easily and have extremely high five-year survival rates (e.g. > 95%), others require multi-year, multi-modal, excruciating therapies. For high-risk tumors, even after years of intense treatments with grueling side effects, the disease frequently relapses (in up to 50% of high-risk cases). When a child relapses his/her neuroblastoma, the future is largely unknown, as there is no standard of care for relapsed disease.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Greason, Christie
Advisors dc:contributor.advisor
  • Garcia-Diaz, Jesus Fernando
  • Zheng, Ye

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51317

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Greason, Christie. The uncertain world of relapsed neuroblastoma: the quest for treatment options in a complex, fatal childhood disease. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51317